Pharmaceuticals

Global GLP-1 Receptor Agonist Market Revenue and Share Analysis Through 2029

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the glp-1 receptor agonist market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The GLP-1 Receptor Agonist Market In The Period 2029-2034?

The GLP-1 receptor agonist market has shown consistent expansion in recent years. It is anticipated to increase from $13.58 billion in 2024 to $14.09 billion in 2025, achieving a compound annual growth rate (CAGR) of 3.8%. The growth observed in the past can be credited to the escalating prevalence of diabetes, proven clinical efficacy, improved patient awareness and acceptance, worldwide health initiatives, and patients’ inclination towards injectable therapies.

The market for GLP-1 receptor agonists is anticipated to experience robust expansion over the coming years. This market is projected to reach $17.36 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.4%. This anticipated growth during the forecast period is driven by factors such as a heightened focus on lifestyle management, the evolution of personalized medicine approaches, an increase in approved indications, the creation of next-generation products, and their incorporation into combination therapies. Key trends characterizing this period are expected to encompass the launch of oral formulations, a significant emphasis on combination therapies, the formation of strategic partnerships and collaborations, developments in reimbursement policies and patient access, and a shift towards more patient-centric approaches.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9631&type=smp

What Strategic Drivers Are Accelerating The GLP-1 Receptor Agonist Market Expansion?

The increasing incidence of diabetes is projected to drive the GLP-1 receptor agonist market forward. Diabetes is a chronic disease that occurs when the pancreas either does not produce sufficient insulin or the body cannot properly use the insulin it produces. High blood sugar is a characteristic symptom of this metabolic disorder. GLP-1 receptor agonists are utilized in diabetes treatment to stimulate the body to generate more insulin, which assists in lowering blood sugar levels; thus, the rising prevalence of diabetes will fuel market expansion. For example, in March 2024, figures from the Office for Health Improvement and Disparities, a UK government department, indicated that between March 2022 and March 2023, the proportion of individuals with type 1 diabetes undergoing all eight recommended care processes grew by 22%, and for type 2 diabetes, it increased by 21%. Additionally, the percentage achieving target HbA1c levels climbed to 37.9%, representing the highest value ever documented by the National Diabetes Audit (NDA). Consequently, the growing prevalence of diabetes is a key driver for the GLP-1 receptor agonist market.

What Is The Detailed Segment Distribution Of The GLP-1 Receptor Agonist Market?

The glp-1 receptor agonist market covered in this report is segmented –

1) By Drug Class: Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs

2) By Route Of Administration: Parenteral, Oral

3) By End Users: Hospitals, Surgical Clinics, Other Users

Subsegments:

1) By Exenatide: Byetta, Bydureon

2) By Liraglutide: Victoza, Saxenda

3) By Dulaglutide: Trulicity

4) By Lixisenatide: Adlyxin

5) By Other Drugs: Semaglutide, Tirzepatide, Others

How Are Global Trends Impacting The Development Of The GLP-1 Receptor Agonist Market?

A significant and growing trend within the GLP-1 receptor agonist market involves product innovations. Major companies operating in the GLP-1 receptor agonist market are concentrating on creating innovative solutions to enhance their competitive standing. For instance, in May 2022, Eli Lilly and Company, a US-based pharmaceutical company that creates beneficial medicines, launched its new FDA-approved Mounjaro, which functions as a GIP and GLP-1 receptor agonist. This product is uniquely designed using a single molecule that activates the body’s receptors for the incretin hormones GIP and GLP-1. It is provided as a pen auto-injector, complete with a pre-attached, hidden needle that patients are not required to handle or see, and it is available in 6 doses.

Who Are The Major Stakeholders Operating In The GLP-1 Receptor Agonist Market?

Major companies operating in the GLP-1 receptor agonist market include Novo Nordisk A/S, Sanofi SA, Eli Lilly and Company, AstraZeneca Inc., Boehringer Ingelheim International GmbH, Hanmi Pharm Co. Ltd., Pfizer Inc., Amgen Inc., Innovent Biologics Inc., Jiangsu Hengrui Medicine Co., Sun Pharmaceuticals Industries Ltd., PegBio Co. Ltd., Zealand Pharma A/S, Bristol-Myers Squibb Company, Chongqing Lummy Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited, Dong-A ST Co. Ltd., Eisai Co. Ltd., HanAll Biopharma Co. Ltd., Ipsen SA, Johnson & Johnson, Merck & Co. Inc., Novartis AG

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/glp-1-receptor-agonist-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The GLP-1 Receptor Agonist Market?

North America was the largest region in the GLP-1 receptor agonist market in 2024. Asia-Pacific is expected to be the fastest-growing region in the GLP-1 receptor agonist market report during the forecast period. The regions covered in the GLP-1 receptor agonist market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9631&type=smp

Browse Through More Reports Similar to the Global GLP-1 Receptor Agonist Market 2025, By The Business Research Company

Blood And Blood Components Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Blood Group Typing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

Blood Glucose Meters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795